Consequently, we hypothesized that CaD might reduce monocyte-to-macrophage differentiation, one specific hallmark of inflammation (and atherosclerosis) that involves signaling via PKCδ and MAPK, previously shown as mediators of CaD activity in a diabetes model [14,37]. This evidence concerns the gene CAD and atherosclerosis.